Ariad Ruling Bolsters Written Description Requirement
While the ruling in Ariad Pharmaceuticals Inc.'s closely watched patent infringement case against Eli Lilly & Co. confirmed existing law, intellectual property attorneys say the court's decision will shine a spotlight...To view the full article, register now.
Already a subscriber? Click here to view full article